Corcept Therapeutics (CORT) Reports Q4 EPS of $0.77
Tweet
Share
E-mailGet Alerts CORT Hot Sheet
Price: $122.25 +0.99%
Financial Fact:
Net loss and comprehensive loss: 2.59M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Net loss and comprehensive loss: 2.59M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Corcept Therapeutics (NASDAQ: CORT) reported Q4 EPS of $0.77, versus $0.04 reported last year. Revenue for the quarter came in at $53.3 million, versus $23.8 million reported last year.
GUIDANCE:
Corcept Therapeutics sees FY2018 revenue of $275-300 million.
For earnings history and earnings-related data on Corcept Therapeutics (CORT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Truist Securities Assumes Corcept Therapeutics (CORT) at Buy
- Analog Devices (ADI) Tops Q3 EPS by 11c, Beats on Revenue; Offers Q4 Guidance
- Nordson Corp. (NDSN) Tops Q3 EPS by 16c; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
